financetom
Business
financetom
/
Business
/
Nvidia Q4 Results to be 'Massive' Day for Markets, Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia Q4 Results to be 'Massive' Day for Markets, Wedbush Says
Feb 25, 2025 8:40 AM

11:17 AM EST, 02/25/2025 (MT Newswires) -- Nvidia ( NVDA ) will provide a gauge for the demand trajectory of the AI Revolution with its Q4 financial results Wednesday, Wedbush said in a Tuesday note.

"Tomorrow is a massive day for the global markets," Wedbush analysts, including Daniel Ives, said.

They said the focus will be if another "$2 billion beat and $2 billion raise" is in the cards as the market is heavily skewed negative right now around tech sentiment.

The analysts said they expect another robust performance and "clear beat and raise special" from Nvidia ( NVDA ) that should calm the nerves of investors.

"We believe demand is far outstripping supply with Blackwell in the field," they said. "After speaking with many enterprise AI customers we have seen NOT ONE AI enterprise deployment slow down or change due to the DeepSeek situation."

Price: 126.99, Change: -3.30, Percent Change: -2.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
South Korea wants workers detained in immigration raid to be able to re-enter US
South Korea wants workers detained in immigration raid to be able to re-enter US
Sep 8, 2025
* Hyundai, LG Energy's $4.3 billion project site in Georgia raided * South Korea plans chartered flight for detained workers' return * Seoul also seeking to have US visa system for Koreans streamlined (Recasts and writes through with foreign and finance ministers' comments) By Joyce Lee and Hyunjoo Jin SEOUL, Sept 8 (Reuters) - South Korea said on Monday that...
Merck Says Phase 2 Study of Potential Lung Cancer Drug Showed 'Clinically Meaningful' Response Rates
Merck Says Phase 2 Study of Potential Lung Cancer Drug Showed 'Clinically Meaningful' Response Rates
Sep 8, 2025
05:35 AM EDT, 09/08/2025 (MT Newswires) -- Merck ( MRK ) said Sunday that results from its IDeate-Lung01 phase 2 trial evaluating ifinatamab deruxtecan in patients with previously treated extensive-stage small cell lung cancer showed clinically meaningful response rates. The company said patients who received ifinatamab deruxtecan in both parts of its trial, dose optimization and single-arm expansion, displayed an...
Computershare launches investment engagement business, hires executive for North America
Computershare launches investment engagement business, hires executive for North America
Sep 8, 2025
NEW YORK, Sept 8(Reuters) - Computershare ( CMSQF ) is launching an investor engagement business and hired a JPMorgan Chase ( JPM ) executive at a time corporate management teams are looking for more advice on how to handle shareholder relations, including demands for improvements, the global financial services company said. Computershare's ( CMSQF ) new investor engagement business will...
Update: Ideaya, Partner Say Small Cell Lung Cancer Phase 1 Trial Shows Strong Response Rate
Update: Ideaya, Partner Say Small Cell Lung Cancer Phase 1 Trial Shows Strong Response Rate
Sep 8, 2025
05:16 AM EDT, 09/08/2025 (MT Newswires) -- (Updates with the stock price movement in the last paragraph.) Ideaya Biosciences ( IDYA ) and Hengrui Pharma said Sunday that initial data from a phase 1 trial of the experimental IDE849 small cell lung cancer treatment showed strong overall response and disease control rates across all tested doses and stages of treatment,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved